Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
It is intended for contrast enhancement in MRI scans
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
Subscribe To Our Newsletter & Stay Updated
